Takeda Pharmaceutical Co Ltd
CIK 0001395064
10% Owner
Filings
5
Latest Dec 9, 2025
Issuers covered
4
Showing
5 of 5
Page 1
Track record
2 of 2 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 2 | 0% | -39.7% | -39.7% | -21.3% | -58.1% |
| 90 days | 2 | 50% | +6.2% | +6.2% | +47.4% | -35.1% |
| 180 days | 2 | 50% | -30.5% | -30.5% | +16.1% | -77.2% |
| 365 days | 2 | 50% | +17.4% | +17.4% | +41.8% | -6.9% |
Issuers
Companies where Takeda Pharmaceutical Co Ltd has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| PHAT | Phathom Pharmaceuticals, Inc. | 2 | Jan 25, 2024 |
| CALA | Calithera Biosciences, Inc. | 1 | May 26, 2023 |
| HLVX | Hillevax, Inc. | 1 | Sep 19, 2025 |
| OVID | Ovid Therapeutics Inc. | 1 | Dec 9, 2025 |
All filings
5 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|